Vicore Pharma Holding AB (VICO) Stock Statistics & Valuation Metrics

Vicore Pharma Holding AB has a market cap or net worth of kr2.01B. The enterprise value is kr1.01B.

Vicore Pharma Holding AB has 234,579,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vicore Pharma Holding AB’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -17.16%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Vicore Pharma Holding AB had revenue of 109.35M and earned -168.63M in profits. Earnings per share was -0.75.

In the last 12 months, operating cash flow was -274.14M and capital expenditures -15.25M, giving a free cash flow of -274.14M billion.

Vicore Pharma Holding AB pays an annual dividend of kr3.223, resulting in a dividend yield of ―

Vicore Pharma Holding AB upcoming earnings date is Aug 22, 2025, TBA (Confirmed).

Vicore Pharma Holding AB as a current ratio of 16.50, with Debt / Equity ratio of 0.00%

In the past 12 months, Vicore Pharma Holding AB has paid -256.00K in taxes.

Vicore Pharma Holding AB EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of >-0.01.

Vicore Pharma Holding AB has kr1.05B in cash and marketable securities with kr0.00 in debt, giving a net cash position of -kr1.05B billion.

Gross margin is 76.65%, with operating margin of -177.59%, and net profit margin of -154.22%.

The average price target for Vicore Pharma Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―